On ECHEMI
Home > Drugs > Xinxiang Changle Pharmaceutical Co., Ltd.
Xinxiang Changle Pharmaceutical Co., Ltd.
  • Founded in:

    2002-07-19
  • Country:

    China China
  • Address:

    East Suburb of Huixian City, Henan Province
  • Tax NO.:

    91410782740724979U
  • Registered Funds:

    39.58 million yuan
  • Website:

  • Email:

Related Drugs
Vitamin B6 tablets
Each tablet of this product contains 10 mg of vitamin B6, the main ingredient, and the auxiliary materials are starch, dextrin and magnesium stearate.
Name Description Content CAS NO. Registered Holders
Vitamin B6

Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin.

More

Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin.

10mg 8059-24-3 13
Starch

Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin.

More

Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin.

9005-25-8 78
Dextrin

Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin.

More

Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin.

9004-53-9 50
Magnesium stearate

Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin.

More

Vitamin B6 is an important component of coenzymes, involved in the normal metabolism of sugar, protein, and fat, and is related to the production of white blood cells and hemoglobin.

557-04-0 61
Compound diphenoxylate tablets
This product is a compound preparation. Its main ingredient is diphenoxylate. Chemical name: 1-(3,3-diphenyl-3-cyanopropyl)-4-phenyl-4-piperidinic acid ethyl ester hydrochloride
Name Description Content CAS NO. Registered Holders
Diphenoxylate

No specific description of pharmacological action is provided

More

No specific description of pharmacological action is provided

0
Diltiazem Hydrochloride Tablets
The main ingredients and chemical names of this product are: cis-()-5-[(2-dimethylamino)ethyl]-2-(4-methoxyphenyl)-3-acetoxy-2,3-dihydro-1,5-phenylpropylthiazepine-4(5H)-one hydrochloride
Name Description Content CAS NO. Registered Holders
Diltiazem hydrochloride

This product is a calcium channel blocker, and its action is related to the inhibition of calcium ion influx during myocardial and vascular smooth muscle depolarization. This product can effectively dilate the epicardial and subendocardial coronary arteries, relieve spontaneous angina pectoris or angina pectoris caused by coronary artery spasm induced by ergonovine; by slowing down the heart rate and lowering blood pressure, it reduces myocardial oxygen demand, increases exercise tolerance and relieves exertional angina pectoris. This product can relax vascular smooth muscle, reduce peripheral vascular resistance, and lower blood pressure; the extent of its blood pressure reduction is related to the degree of hypertension, and only slightly reduces blood pressure in people with normal blood pressure. This product has a negative inotropic effect and can slow down the conduction of the sinoatrial node and atrioventricular node.

More

This product is a calcium channel blocker, and its action is related to the inhibition of calcium ion influx during myocardial and vascular smooth muscle depolarization. This product can effectively dilate the epicardial and subendocardial coronary arteries, relieve spontaneous angina pectoris or angina pectoris caused by coronary artery spasm induced by ergonovine; by slowing down the heart rate and lowering blood pressure, it reduces myocardial oxygen demand, increases exercise tolerance and relieves exertional angina pectoris. This product can relax vascular smooth muscle, reduce peripheral vascular resistance, and lower blood pressure; the extent of its blood pressure reduction is related to the degree of hypertension, and only slightly reduces blood pressure in people with normal blood pressure. This product has a negative inotropic effect and can slow down the conduction of the sinoatrial node and atrioventricular node.

33286-22-5 41
Ethamethamide injection
Phenolsulfonylamine, chemical name: 2,5-dihydroxybenzenesulfonic acid diethylamine salt
Name Description Content CAS NO. Registered Holders
Etamsylate

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

More

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

2624-44-4 11
Ribavirin Tablets
Ribavirin
Name Description Content CAS NO. Registered Holders
Ribavirin

Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. This product does not change the adsorption, invasion and uncoating of viruses, nor does it induce the production of interferon. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

More

Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. This product does not change the adsorption, invasion and uncoating of viruses, nor does it induce the production of interferon. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

36791-04-5 33
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.